MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » GE Healthcare, Mission Health ink 10-year outcomes-based development deal

GE Healthcare, Mission Health ink 10-year outcomes-based development deal

By

GE HealthcareGE Healthcare (NYSE:GE) said today that it inked a 10-year, outcomes-based development deal with Mission Health to streamline care and improve cost efficiency at Mission Health’s facilities.

Through the partnership, the companies will co-develop, pilot and deploy healthcare solutions focused on optimizing patient imaging experiences and smoothing out patient care transitions.

“This is an innovative, collaborative, outcomes-driven relationship focused on developing new, transformational ways of caring for patients at Mission Health and nationwide. The challenges we face at Mission are like so many health systems across the nation. Our goal is to improve our margin, drive system-wide efficiency and deliver an exceptional, transparent experience for every patient, family and team member. The solutions that we develop and cost savings we achieve with GE will be scalable and applicable to other similar healthcare systems. This is truly exciting for Mission and the industry,” Mission Health CEO Dr. Ronald Paulus said in a press release.

The companies will collaborate to streamline the patient imaging process, including selecting the right imaging modality, time frame and location across the system, and will leverage predictive modeling and analytics to streamline the entire patient care experience.

“To make this level of partnership possible, it takes two organizations to think both differently and collaboratively. We are honored to work with Mission Health and strongly believe that this strategic, outcomes-based agreement will ensure alignment and focus on shared priorities. We are passionate about delivering on our commitment while helping to enhance clinical quality, patient experience and operational efficiency,” GE Healthcare CEO John Flannery said in prepared remarks.

Focal points for the collaboration will include improving radiology screenings, transforming bedside monitoring practices and systems and asset optimization for radiology and biomedical services, the companies said.

Earlier this month, GE Healthcare said it inked a distribution deal with CS Medical to distribute its TD 100 esophageal ultrasound probe disinfector in the U.S.

The TD 100 device, designed to use CS Medical’s TD-5 disinfectant, is the only automated TEE probe disinfector to be tested and approved by “the major TEE manufacturers,” the company claimed.

In case you missed it

RSS From Medical Design & Outsourcing

  • Henry Schein investors push back on executive pay
    Nearly half of Henry Schein (Nasdaq:HSIC) shareholders who voted at this month’s annual meeting voted against the company’s pay packages for top executives, according to a new SEC filing. About 48.5% of voting shareholders voted against the company’s executive pay plan in what’s known as the Say-on-Pay vote, according to vote results of the May… […]
  • Creo Medical inks collaboration agreement with Intuitive
    Creo Medical Group (LON: CREO) announced today that it has signed a multi-year collaboration agreement with Intuitive to make certain Creo surgical technologies compatible with the surgical robotic giant’s systems. The London exchange reacted by sending CREO shares up more than 4% to 100 pence apiece by the close of trading today. As of midday… […]
  • MedTrace Pharma moves forward on 15 O-water imaging tech
    MedTrace Pharma announced the first person scanned in its Rapid-Water-Flow Phase 3 clinical trial, further testing its tech to bring 15 O-water to imaging. The first subject scan took place at Aarhus University Hospital in Denmark, using 15 O-water produced, dosed and injected through MedTrace’s P3 automated delivery system. The clinical trial aims to evaluate… […]
  • Zimmer Biomet narrowly avoids shareholder rebuke on executive pay
    An unusually large share of Zimmer Biomet (NYSE:ZBH) investors voted against the orthopedics company’s pay packages for top executives at the annual shareholder meeting. About 54% of voting shareholders supported the pay packages of the company’s five top-paid executives at the May 13 meeting, according to results filed with the SEC yesterday. In 2021, nearly 93%… […]
  • BD, Mitsubishi Gas Chemical partner on better materials for plastic syringes
    BD (NYSE:BDX) announced that it partnered with Mitsubishi Gas Chemical Company on applying new technology to pre-fillable syringes. MGC develops the Oxycapt technology designed to integrate the best of plastic and glass for plastic syringes. BD and Tokyo-based MGC will work together to apply Oxycapt technology to the next generation of pre-fillable syringes (PFS) for advanced… […]
  • Ambu replaces CEO with new leadership
    Ambu today said it has hired board member Britt Meelby Jensen to replace CEO Juan Jose Gonzalez, effective tomorrow. “Since Juan Jose Gonzalez joined as CEO in 2019, Ambu has made good progress and achieved important milestones on the strategic transformation into the world’s largest single-use endoscopy company,” Ambu Chair Jørgen Jensen said in a… […]
  • AdvaMed joins Biden’s Joint Supply Chain Resilience Working Group
    AdvaMed executive Abby Pratt has joined the executive committee for the Biden administration’s Joint Supply Chain Resilience Working Group, the medtech industry association said today. The working group’s members from government and industry will assist with implementation of the National Strategy for a Resilient Public Health Supply Chain. Pratt oversees supply chain issues as SVP… […]
  • Toray develops new stretchable film for medical devices
    Toray Industries has a new stretchable film based on its proprietary polymer Reactis technology, with potential applications that include robotics and biological and industrial sensors. Tokyo-based Toray said it shipped samples to customers and plans research and development efforts to commercialize the new grade of film. “Recent years have increased the potential for developing stretchable… […]
  • Google Health hires FDA’s chief digital health officer
    Former FDA Chief Digital Health Officer of Global Strategy and Innovation Bakul Patel has started a new job with Google after 13 years with the regulatory agency. Patel became senior director, global digital health strategy and regulatory for Google Health earlier this month, he said on LinkedIn. Patel recounted highlights of his “incredible journey since… […]
  • Expect more heart and lung failure years after COVID, Abbott’s heart failure CMO says
    Two years into the COVID-19 pandemic, we know more than ever about the SARS-CoV-2 virus and how quickly it moves to ravage the human body. What remains to be seen is how the virus — and perhaps more importantly, our immune system’s response to it — will affect the health of people long after infection,… […]
  • FDA moves forward with Voluntary Improvement Program to bolster medical device quality
    Kathryn Burke, Emergo Group The U.S. Food and Drug Administration has issued new draft guidance to establish a full-blown voluntary program for improving quality-related processes in medical device manufacturing following promising results of a pilot program. The FDA guidance stems from a pilot undertaken by the agency along with the Medical Device Innovation Consortium (MDIC) in 2018.… […]